
A Joint Venture of Quintiles and Thermo Fisher Scientific
CENDUIT NEWS
January 28, 2010 - Cenduit and invivodata, inc. Align to Integrate Clinical IRT and ePRO SolutionsDecember 9, 2009 - Cenduit Selects SAP BusinessObjects to Revolutionize Clinical Trial Reporting & Analytics
May 26, 2009 - Cenduit Announces New Vice President, Global Sales and Marketing
April 23, 2008 - Executives Join Cenduit’s Team

invivodata, inc.
Cenduit, LLC and invivodata, inc. formed a strategic business alliance to further improve clinical trial efficiencies by adding the scientific and operational benefits of invivodata’s electronic Patient Reported Outcomes (ePRO) solutions to the proven efficiencies of Cenduit‘s Interactive Response Technology solution (IRT).
Cenduit’s IRT solution is instrumental in collecting, analyzing and managing clinical trial data. Cenduit’s clients — pharmaceutical, clinical research and biotechnology organizations — rely on IRT solutions to effectively manage randomization and drug supply management of their clinical studies. The invivodata ePRO solution provides for Electronic Patient Reported Data Capture which enhances the speed, efficiency, and accuracy of patient reporting in clinical trials. This business alliance with Cenduit takes the business efficiencies of its proven IRT solution to the next level.
Through its strategic alliance with invivodata, the leading provider of electronic Patient Reported Outcomes solutions for clinical research, Cenduit’s solution incorporates a best-in-class ePRO offering that allows electronic diary data to be collected, analyzed, and disseminated patient study data captured through IRT, Web, handheld devices or tablet PCs.
Business intelligence gleaned from trends in programs over time will help clinical trial personnel devise meaningful strategies by transforming data collection and data-driven decision-making throughout the drug supply chain management to achieve substantial study efficiencies and cost savings.
